慢性HBV/HCV感染合并轻度肝脂肪变的临床特点分析

何佳; 李威; 李宽; 宁会彬; 刘俊平; 毛重山; 尚佳

doi:10.3969/j.issn.1001-5256.2016.09.016

慢性HBV/HCV感染合并轻度肝脂肪变的临床特点分析

DOI: 10.3969/j.issn.1001-5256.2016.09.016

郑州大学人民医院河南省人民医院感染科

基金项目:

河南省科技厅计划项目(162102310284)；

详细信息

中图分类号: R512.6;R575.5
计量
- 文章访问数: 2496
- HTML全文浏览量: 10
- PDF下载量: 453
- 被引次数: 0
出版历程
- 出版日期: 2016-09-20

Clinical features of chronic HBV/HCV infection complicated by mild hepatic steatosis

Department of Infectious Diseases, Zhengzhou University People′s Hospital & Henan Province People′s Hospital

Research funding:

摘要

摘要: 目的比较初治慢性HBV/HCV感染合并轻度肝脂肪变患者的临床特点。方法收集2014年12月-2016年1月在郑州大学人民医院住院的初治慢性HBV/HCV感染者111例,全部患者经肝穿刺明确合并有轻度肝脂肪变,其中HBV感染者65例（HBV感染组）,HCV感染者46例（HCV感染组）。比较两组患者的肝功能、血脂、血糖、肝脏硬度值（LSM）等临床指标变化。计量资料组间比较采用独立样本t检验或Wilcoxon秩和检验,计数资料组间比较采用χ2检验。结果两组患者LSM、AST、GGT、血浆Alb、TC、HDL-C、LDL-C、PLT比较,差异均有统计学意义（P值均<0.05）。将两组患者按照肝脏炎症分级和纤维化分期分为G或S<2组（0、01、1、12）,G或S≥2组（2、23、34、4）。LSM在HBV感染组和HCV感染组不同肝脏炎症分级以及不同纤维化分期的组间比较,差异均有统计学意义[HBV感染组:6.40（5.307.70）vs 8.30（5.90...
- 肝炎病毒,乙型 /
- 肝炎病毒属 /
- 脂肪肝
Abstract: Objective To investigate the clinical features of previously untreated patients with chronic HBV/HCV infection complicated by mild hepatic steatosis. Methods A total of 111 previously untreated patients with chronic HBV/HCV infection who were hospitalized in Zhengzhou University People's Hospital from December 2014 to January 2016. Liver biopsy confirmed that all the patients had mild hepatic steatosis. Among these patients,65 had HBV infection and 46 had HCV infection. The changes in clinical indices such as liver function,blood lipid,blood glucose,and liver stiffness measurement( LSM) were compared between the two groups. The independent samples t- test or Wilcoxon two- sample test was used for comparison of continuous data between groups,and the chi- square test was used for comparison of categorical data between groups. Results There were significant differences in LSM,aspartate aminotransferase( AST),gamma- glutamyl transpeptidase( GGT),plasma albumin( Alb),total cholesterol( TC),high- density lipoprotein cholesterol( HDL- C),low- density lipoprotein cholesterol( LDL- C),and platelet count( PLT) between the two groups( all P < 0. 05). According to liver inflammation grade and fibrosis stage,the patients were divided into G < 2/S < 2 group( 0,0- 1,1,1- 2) and G≥2/S≥2 group( 2,2- 3,3- 4,4). LSM showed significant differences across the groups with different liver inflammation grades and fibrosis stages( HBV infection: 6. 40( 5. 30 ~ 7. 70) vs 8. 30( 5. 90 ~ 11. 30),Z =- 2. 463,P = 0. 014; 6. 70( 5. 30 ~ 7. 80) vs 8. 30( 5. 70 ~ 11. 30),Z =- 2. 049,P = 0. 040。HCV infection: 7. 60( 6. 30 ~ 11. 50) vs 17. 50( 12. 00 ~ 26. 70),Z =- 3. 961,P < 0. 001; 7. 60( 5. 90 ~ 10. 20) vs 15. 50( 7. 50 ~ 21. 50),Z =- 3. 325,P = 0. 001). In the patients with chronic HCV infection,TC showed a significant difference between the groups with different fibrosis stages( 4. 28 ± 0. 85 vs 3. 82 ± 0. 68,t = 2. 045,P = 0. 047). Conclusion Compared with the previously untreated patients with chronic HBV infection complicated by mild hepatic steatosis,those with HCV infection complicated by mild hepatic steatosis have higher LSM,GGT,TC,and LDL- C,as well as lower Alb,PLT,AST,and HDL- C. In addition,the parameters associated with hepatic steatosis( BMI,GLU,fat attenuation parameter,blood lipid) are not positively correlated with disease progression.
- hepatitis B virus /
- hepacivirus /
- fatty liver

HTML全文

参考文献(21)

[1]HSU CS,LIU WL,KAO JH,et al.Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection[J].Hepatol Int,2015,9(2):231-242.

[2]CHALASANI N,YOUNOSSI Z,LAVINE JE,et al.The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Association for the Study of Liver Diseases,American College of Gastroenterology,and the American Gastroenterological Association[J].Hepatology,2012,55(6):2005-2023.

[3]CHEN CL,YANG WS,YANG HI,et al.Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers:a prospective study in taiwan[J].Cancer Epidemiol Biomarkers Prev,2014,23(8):1659-1671.

[4]ARANO T,NAKAGAWA H,TATEISHI R,et al.Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients[J].Int J Cancer,2011,129(9):2226-2235.

[5] Chinese Society of Hepatology,Chinese Society of Infections Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J].Chin J Intern Med,2011,50(2):168-179.(in Chinese)中华医学会肝病学分会,中学医学会感染病学分会.慢性乙型肝炎防治指南(2010版)[J].中华内科杂志,2011,50(2):168-179.

[6]Chinese Society of Hepatology and Chinese Society of Infectious Diseases and Parasitology,Chinese Medical Association.Guidelines for prevention and treatment of hepatitis C[J].Natl Med J China,2004,84(9):775-780.(in Chinese)中华医学会肝病学分会、传染病与寄生虫病学分会.丙型肝炎防治指南[J].中华医学杂志,2004,84(9):775-780.

[7]LEMOINE M,RATZIU V,KIM M,et al.Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease[J].Liver Int,2009,29(9):1431-1438.

[8]KHATTAB MA,ESLAM M,ALY MM,et al.Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4[J].J Clin Gastroenterol,2012,46(10):871-879.

[9]HUI CK,ZHANG HY,LEE NP,et al.Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B[J].J Hepatol,2007,47(2):191-202.

[10]WONG VW,WONG GL,YU J,et al.Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese[J].Am J Gastroenterol,2010,105(1):132-138.

[11]ERKAN G,YILMAZ G,CENGIZ M,et al.Lack of association of hepatic estrogen receptor-alpha expression with histopathological and biochemical findings in chronic hepatitis C[J].Pathol Res Pract,2013,24(5):993-998.

[12]WANG XY,CHENG SY.Hepatitis C virus detection method[J].Chinese J Exp Clin Virol,2011,25(2):158-161.(in Chinese)王晓艳,陈斯勇.丙型肝炎病毒的病毒学检测方法[J].中华实验和临床病毒学杂志,2011,25(2):158-161.

[13]KIM KH,SHIN HJ,KIM K,et al.Hepatitis B virus X protein induces hepatic steatosis via transcripyional activation of SREBP 1 and PPAR gamma[J].Gastroenterology,2007,132(5):1955-1967.

[14]LEE DH,JACOBS DR Jr,GROSS M,et al.Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes:the Coronary ArteryRisk Development in Young Adults(CARDIA)Study[J].Clin Chem,2005,51(7):1185-1191.

[15]RYU S,CHANG Y,KIM DI,et al.Gamma-glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men[J].Clin Chem,2007,53(1):71-77.

[16]BANDERAS DZ,ESCOBEDO J,GONZALEZ E,et al.γ-glutamyl transferase:a marker of nonalcoholic fatty liver disease in patients with the meta-bolic syndrome[J].Eur J Gastroenterol Hepatol,2012,24(7):805-810.

[17]PUOTI C,GUARISCO R,BELLIS L,et al.Diagnosis,management,and treatment of hepatitis C[J].Hepatology,2009,50(1):322-325.

[18]MA ZZ,LU LG.Nonalcoholic fatty liver disease and liver cirrhosis[J].J Prac Hepatol,2016,19(2):135-138.(in Chinese)马振增,陆伦根.非酒精性脂肪性肝病与肝硬化[J].实用肝脏病杂志,2016,19(2):135-138.

[19]WAI CT,GREENSON JK,FONTANA R,et al.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J].Hepatology,2003,38(2):518-526.

[20] SCOTT DR,LEVY MT.Liver transient elastography(Fibroscan):aplace in the management algorithms of chronic vifal hepatitis[J].Antivir ther,2010,15(1):1-11.

[21]SHAHEEN AA,WAN AF,MYERS RP.Fibrotest and Fibroscan for the prediction of hepatitis C related fibrosis:a systematic review of diagnostic test accuracy[J].Am J Gastroenterol,2007,102(11):2589-2600.

施引文献

资源附件(0)

访问统计